Frazier Life Sciences VIII, L.P. is 10% Owner at ALPINE IMMUNE SCIENCES, INC. (ALPN). They have made 1 open-market trade across 1 company since 2019, most recently 2019-01-18.
CIK 0001655827
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALPN | 2,571,450 | $167.1M |
Shares reported on the most recent Form 4, priced at the 2019-01-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALPN | BUY | 2019-01-18 | 2019-01-22 | $5.37 | $2.0M | +3.4% | -3.2% | +16.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.